Hamilton James C

Hamilton James C is listed in filings as Chief Discovery/Trans Medicine at Arrowhead Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Apr 24, 2026, including sale activity. Recent filings connect the profile to Arrowhead Pharmaceuticals Inc (ARWR). The current snapshot covers public activity from Jan 7, 2025 to Apr 24, 2026. Reported amounts are shown as $220.6K to $187.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.